Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Rising burden of gallbladder and biliary tract cancer

Written by | 27 Mar 2021

Although cancers that occur in the gallbladder or bile ducts are rare, their rates are increasing. A recent study provides details on the burden of gallbladder and biliary… read more.

Lung cancer resistance: the key is glucose

Written by | 26 Mar 2021

Cancers are not only made of tumour cells. In fact, as they grow, they develop an entire cellular ecosystem within and around them. This “tumour microenvironment” is made… read more.

New class of drug leads to 30% reduced risk of death for bladder cancer patients

Written by | 27 Feb 2021

A new type of drug that helps target chemotherapy directly to cancer cells has been found to significantly increase survival of patients with the most common form of… read more.

Cabozantinib most effective treatment for metastatic papillary kidney cancer

Written by | 25 Feb 2021

In a SWOG Cancer Research Network trial that put three targeted drugs to the test, the small molecule inhibitor cabozantinib was found most effective in treating patients with… read more.

Targeted drug combination improves survival in advanced kidney cancer

Written by | 24 Feb 2021

Lenvatinib plus pembrolizumab yields better overall survival than single-agent sunitinib when given as first-line therapy in untreated patients with metastatic kidney cancer. The combination also improved progression-free survival… read more.

1 in 8 patients with cancer harbour inherited genetic mutations

Written by | 12 Dec 2020

Genetic testing can uncover inherited genetic mutations, and could individualize cancer therapies, improve survival, manage cancer in loved ones and push the boundaries of precision medicine.

Delayed surgery increases cancer risk

Written by | 2 Dec 2020

Article written by Gary Finnegan. The rescheduling of surgeries early in the COVID-19 pandemic has had a significant impact on cancer survival rates.

Cholesterol medications linked to lower cancer-related deaths in women

Written by | 9 Nov 2020

Among women with breast cancer, colorectal cancer, or melanoma, those who were taking cholesterol-lowering medications, were less likely to die from cancer, according to an analysis published in… read more.

Drug combo shows promise in bile duct cancer with mutations

Written by | 8 Nov 2020

Article written by Bruce Sylvester Dabrafenib plus trametinib combination appears to be a promising treatment for patients with bile duct cancer (biliary tract cancer) with BRAF V600E mutations. Researchers… read more.

Coffee linked to survival in metastatic colorectal cancer

Written by | 20 Oct 2020

Article written by Bruce Sylvester. Coffee consumption by patients with metastatic colorectal cancer is associated with longer survival, researchers reported on Sept. 17, 2020 in JAMA Oncology.

Differentiation of the coughs – cancer or covid-19?

Written by | 17 Sep 2020

Interview and article by Christine Clark Differentiation of the Cs is a document aimed at health care professionals working in primary care to help them to triage their… read more.

Sedentary adults at greater risk of cancer mortality

Written by | 25 Aug 2020

Article written by Bruce Sylvester Physical inactivity is independently associated with an elevated risk of dying from cancer, researchers reported on June 18, 2020 in JAMA Oncology.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.